This joint presentation results from the strategic agreement signed between the two entities in July, 2011.
Ciaran Cooper will be responsible for developing the company’s US market in oncology clinical trials
and will assist in managing the relationship between MEDIAN and Quintiles
As sponsor of the Imaging in Cancer Drug Development Conference, London, MEDIAN will make a presentation entitled “Toward better imaging interpretation and management to leverage oncology clinical trial success rates".
Strategic agreement to leverage MEDIAN’s advanced lesion management system (LMS) software applications and associated clinical trial imaging services for early,late-stage or post-approval oncology clinical trials
MEDIAN Technologies has signed a landmark contract with the top pharmaceutical company SANOFI for medical image interpretation and management in a new phase II study on small cells lung cancer.
Presentation of new developments in Oncology Imaging
Participation to presentation sessions about the quantitative Imaging of the future
MEDIAN Technologies Booth 7540, North Building - Hall B
MEDIAN Technologies to participate to the next Journées Françaises de Radiologie 2011, Paris, Palais des Congrès, Porte Maillot. MEDIAN's new developments in oncology imaging will be presented.
Read more 
Download attached PDF File (399.8 Kb) 
Visit website 
